Eritrocyt sedimantation rate

dc.authorid0000-0003-1514-1685
dc.contributor.authorVardi, Şeref
dc.contributor.authorKarabay, Oǧuz
dc.date.accessioned2021-06-23T18:54:16Z
dc.date.available2021-06-23T18:54:16Z
dc.date.issued2006
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractThe ESR is an old, inexpensive, yet still widely used test. The test has a role in rheumatoid arthritis, temporal arteritis, polymyalgia rheumatica and myeloma. It may have an additional role in follow-up of patients with otitis media, osteomyelitis, sickle cell disease, HIV, pelvic inflammatory disease, intravenous drug users, prostate cancer and stroke. The ESR, however, should only be used as a guide. The clinician, when ordering an ESR, should realize that this test is only one parameter that could be helpful in the diagnosis and follow-up of certain inflammatory conditions and also have an important prognostic role in noninflammatory conditions such as prostate cancer, stroke. Thus, we continue to learn about this old yet still important test even today. We present a summary of clinical usefulness of the ESR through out of this review article.en_US
dc.identifier.endpage35en_US
dc.identifier.issn1016-5134
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-33748651500en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage31en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/4349
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-33748651500&partnerID=40&md5=2208b197fe1c13bf1f127964847290e1
dc.identifier.volume18en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorKarabay, Oǧuz
dc.language.isotren_US
dc.relation.ispartofSENDROMen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEritrocyten_US
dc.subjectSedimantation Rate
dc.titleEritrocyt sedimantation rateen_US
dc.title.alternativeEritrosit sedimentasyon hızıen_US
dc.typeReview Articleen_US

Dosyalar